文献速递肝胆胰外科

中央型胆管癌门静脉栓塞后不可切除的预测因素

Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma.
PubMed 文献 · Surgery · 2020-04-24

多因素分析显示腰大肌指数<500 mm2/m2、高BMI和低血清白蛋白与不可切除相关,构建的复合评分AUC达0.82。

要点

  • 门静脉栓塞后36%患者未能切除,最常见原因为肿瘤进展(62%)。
  • 腰大肌指数<500 mm2/m2、高BMI、低白蛋白是不可切除的独立预测因素。
  • 基于上述变量的复合评分可较准确预测不可切除(AUC=0.82)。

核心结论

  • 中央型胆管癌门静脉栓塞后不可切除的预测因素已明确,肌肉减少性超重患者风险更高。
  • 基于腰大肌指数、BMI和白蛋白的术前评分能较准确预测个体不可切除风险。

研究设计与样本

  • 在意向治疗条件下,基于门静脉栓塞前临床、生物学和影像学数据确定不可切除的预测因素。

主要发现

  • 不可切除最常见原因为肿瘤进展(62%)。
  • 多因素分析显示腰大肌指数<500 mm2/m2(P=.04)、高BMI(P=.023)和低血清白蛋白(P=.007)与不可切除相关。
  • 复合评分对不可切除的判别准确,AUC=0.82(P<.001)。

关键数值与推荐

  • 腰大肌指数<500 mm2/m2为不可切除的预测因素(P=.04)。
  • 复合评分包含腰大肌指数、BMI和血清白蛋白,界值由ROC曲线分析确定,AUC=0.82(P<.001)。

临床怎么用

  • 对计划行门静脉栓塞的中央型胆管癌患者,术前可评估腰大肌指数、BMI和血清白蛋白。
  • 使用复合评分辅助识别不可切除高风险患者,以优化治疗决策。

局限性

  • 复合评分的界值基于ROC曲线分析确定,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The curative treatment of perihilar cholangiocarcinomas and centrally located intrahepatic cholangiocarcinomas often requires major hepatectomy preceded by portal vein embolization. This strategy, however, is associated with a high rate of dropouts before operation or failure of resection at the time of operative exploration. We aimed to identify predictors of unresectability (dropout or failure of resection) after portal vein embolization for centrally located cholangiocarcinoma, including perihilar cholangiocarcinomas and intrahepatic cholangiocarcinomas. METHOD: All patients undergoing portal vein embolization for a planned resection of a centrally located cholangiocarcinoma between 2000 and 2018 in our center were evaluated retrospectively. Predictors of unresectability were determined under intention-to-treat conditions, based on clinical, biologic, and radiologic data collected before portal vein embolization. RESULTS: Eighty-eight consecutive patients scheduled for portal vein embolization before operative exploration were included, 56 of whom (64%) underwent curative resection and 32 (36%) of whom were not resected, including those who did not undergo exploration (n = 11) and those operated on but not resected (n = 21). The most common cause of unresectability was tumor progression (62%). A psoas muscle index <500 mm2/m2 (P = .04), high body mass index (P = .023), and low serum albumin level (P = .007) were associated with unresectabilty on multivariate analysis. A composite score including these variables (cutoffs determined after receiver operating characteristic curve analysis) was proposed and achieved accurate discrimination regarding unresectability (area under the curve = 0.82, P < .001). CONCLUSION: Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma were identified, with sarcopenic overweight patients having a greater risk of unresectability. This preoperative score enables a fairly accurate prediction of unresectability in a given patient. These simple, objective, and inexpensive parameters should be considered in all patients with centrally located cholangiocarcinoma scheduled to undergo portal vein embolization.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Abdelrafee A, Nunez J, Cano L, et al. Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma. Surgery. 2020. PMID: 32340719. doi:10.1016/j.surg.2020.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。